Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Is Johnson & Johnson Stock Outperforming the Nasdaq?

With a market cap of $592.4 billion, New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a global healthcare company engaged in the research, development, manufacturing, and sale of a broad range of medical products worldwide. The company serves patients and healthcare professionals through hospitals, wholesalers, retailers, and clinics around the world.

Companies valued at $200 billion or more are generally considered “mega-cap” stocks and Johnson & Johnson fits this criterion perfectly. It operates through two main segments: Innovative Medicine, which focuses on therapies across areas such as oncology, immunology, neuroscience, and cardiovascular disease, and MedTech, which delivers solutions for surgery, orthopedics, cardiovascular care, and vision health. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.